Printer Friendly

The stigma surrounding tuberculosis: even though TB is only listed as a Biological Safety Level-2 agent, the stigma around the disease leads many to overcompensate when designing or revamping a lab.

The respiratory infectious disease once known as consumption is an infection caused by the bacterial complex tubercle bacilli--TB (tuberculosis forming members of the genus Mycobacterium). Highly contagious with an infective dose of less than 10 bacilli, tuberculoses has an estimated 20 million cases worldwide. This represents less than 10% of the total TB carriers.

There were hopes to eradicate tuberculosis; however, drug resistant strains began to show up in the 1980's, giving rise to a new tier of TB--multi-drug resistant TB (MDR TB). Representing a greater threat and risk level, MDR TB is listed in the CDC's Biosafety in Microbiological and Biomedical Laboratories (BMBL), 5th ed. Section 8 of this document is dedicated to Agent Summary Statements', where the CDC outlines the general characteristics of the pathogen and its biosafety and biosecurity recommendations.

Contrary to common discussions, TB is only listed as a Biological Safety Level (BSL)-2 agent; requiring BSL-2 level containment, equipment and practices. This is an excerpt from BMBL on TB: "Laboratory Safety and Containment Recommendations: BSL-2 practices and procedures, containment equipment and facilities are required for non-aerosol-producing manipulations of clinical specimens such as preparation of acid-fast smears. All aerosol-generating activities must be conducted in a BSC. Use of a slide-warming tray, rather than a flame, is recommended for fixation of slides. Liquifaction and concentration of sputa for acid-fast staining may be conducted safely on the open bench by first treating the specimen in a BSC with an equal volume of 5% sodium hypochlorite solution (undiluted household bleach) and waiting 15 minutes before processing."

The significance of this statement will be made clear in a moment, but it is important to point out that it includes not only BSL recommendations, but specific practices to be used and included in SOP generation when working with known or unknown TB-containing samples while performing specific tasks (such as AFB and flaming).

That being said, TB and MDR TB can also be used in labs with protocols requiring BSL-3 recommendations: "BSL-3 practices, containment equipment and facilities are required for laboratory activities in the propagation and manipulation of cultures of any of the subspecies of the M. tuberculosis complex and for animal studies using experimentally or naturally infected NHP. Animal studies using guinea pigs or mice can be conducted at ABSL-2. BSL-3 practices should include the use of respiratory protection and the implementation of specific procedures and use of specialized equipment to prevent and contain aerosols. Disinfectants proven to be tuberculocidal should be used ..."

[ILLUSTRATION OMITTED]

[ILLUSTRATION OMITTED]

The CDC has also released an "Interim Laboratory Biosafety Guidance for Extensively Drug-Resistant (XDR) Mycobacterium Tuberculosis strains." XDR TB is defined as MDR TB that is also resistant to one of three other tuberculocidal drugs: capreomycin, kanamycin and amikacin. This recommendation supersedes the BMBL when working with suspected or known MDR/XDR TB. "The risk of occupational infection from XDR TB strains has not been shown to differ from that of non-resistant M. tuberculosis strains. As described in the 5th edition of ... (BMBL), M. tuberculosis infections are a proven hazard to laboratory personnel as well as others who may be exposed to infectious aerosols in the laboratory, autopsy rooms and other healthcare facilities ..."

BSC classes

To satisfy these recommendations a Biological Safety Cabinet (BSC) is required. This typically suggests non-ventilated Class I or Class II A2 devices. A BSC is used for the capture and control of airborne hazardous aerosols and particulate for the purpose of personal and environmental protection. Unless hazardous chemicals (toxic or volatile) are being used in concentrations or volumes unsafe for environmental recirculation, then the exhaust does not need to be vented to atmosphere.

Yet, many TB labs, including AFB labs utilize total exhaust BSCs, incurring major costs both in the construction and in the lifetime operation of the laboratory. This is driven, primarily, by the stigma surrounding TB by architects and engineers, and enabled by laboratory managers and biosafety officers not being informed and active in the planning process of their facilities. Because of this, a point of contention has arisen regarding the use of externally ducted BSCs to double as HVAC exhaust ports for balancing labs. This opens a cliched Pandora's Box of issues regarding proper installation of Class II A2 canopy and Class II B2 cabinets. But it is important to be aware of and know how to identify over-engineering when building AFB labs, Hot Labs or dedicated TB facilities. Sometimes the simplest looking solution is not the best or easiest solution.

Risk assessments are the most overlooked and underappreciated practices in proposing and designing laboratory spaces and purchasing equipment. Just like the practice of commissioning a new construction, risk assessment reports have the ability to streamline construction and purchasing of the appropriate protective equipment to be installed in the lab. A misstep here could cost a facility tens or even hundreds of thousands of dollars and can delay occupation significantly.

If there is any doubt or further questions concerning recommendations, contact the CDC or a biological safety officer.

Additionally, when building a new lab,. owners/operators of the facility have the ability to challenge decisions being made. If questions arise, reputable equipment manufacturers should be contacted for their professional opinion. Their specialists can often lend a helping hand and get customers pointed in the right direction.

However, as the sole subject matter experts, owners and managers should know lab applications and operations better than anyone. A person's own company should be the primary source for decisions being made when purchasing any type of equipment, but especially costly and regulated safety equipment.

CONTACT

For more information, please contact Labconco Corp. at 816-333-8811, or visit www.labconco.com.

RELATED ARTICLE: At a glance

* TB only requires BSL-2 containment, equipment and practices.

* Recommendations suggest non-ventilated Class I or Class II A2 BSCs when dealing with TB.

* The exhaust does not need to be vented to the atmosphere.

* Many TB labs utilize total exhaust BSCs, incurring extra operating costs.

* Risk assessment reports streamline construction and purchasing of the appropriate protective equipment to be installed in the lab.

by Brian Garrett, Product Specialist, LEED Green Associate, Labconco Corp., Kansas City, MO
COPYRIGHT 2011 Advantage Business Media
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Life Science & Biomedical Labs
Author:Garrett, Brian
Publication:Laboratory Equipment
Date:Nov 1, 2011
Words:1020
Previous Article:Valves speed fluidic set-up.
Next Article:System supports range of sequencing applications.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters